Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BlackRock, Inc. | 2.74M | $116.0M | 7.31% | +187.4K | 2026-06-30 |
| Opaleye Management Inc. | 2.40M | $101.0M | 6.40% | -432.2K | 2026-06-30 |
| Private Capital Management, LLC | 1.62M | $68.0M | 4.31% | +13.3K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.42M | $60.0M | 3.78% | +14.2K | 2026-06-30 |
| CITADEL ADVISORS LLC | 984.3K | $41.0M | 2.63% | +412.9K | 2026-06-30 |
| Deep Track Capital, LP | 969.0K | $41.0M | 2.59% | -- | 2026-06-30 |
| STATE STREET CORP | 939.9K | $39.0M | 2.51% | +84.8K | 2026-06-30 |
| GEODE CAPITAL MANAGEMENT, LLC | 905.6K | $38.0M | 2.42% | +53.5K | 2026-06-30 |
| BAMCO INC /NY/ | 809.4K | $34.0M | 2.16% | -- | 2026-06-30 |
| DIMENSIONAL FUND ADVISORS LP | 667.0K | $28.0M | 1.78% | +87.5K | 2026-06-30 |
